HIV-1 protease inhibitor (Amplyx)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameHIV-1 protease inhibitor (Amplyx)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFK506 binding protein modulatorsHuman immunodeficiency virus type 1 protease inhibitors
TargetsFK506 binding proteinHuman immunodeficiency virus type 1 protease
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmplyx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmplyx Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A